Showing results (71-80 of 78) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Gynecologic Oncology|November 1, 1990
Crossover study with cisplatin or carboplatin in advanced ovarian cancerL Repetto, S Chiara, S Mammoliti, et al.Anticancer Research|March 1, 1996
Efficacy of the association of 13-cis-retinoic acid (13cRA) and alpha-interferon 2a (alpha-IFN 2a) in moderate-severe cervical intraepithelial neoplasia (CIN II-III): a pilot studyS Toma, N Ragni, P Raffo, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Adjuvant cisplatin-based chemotherapy for stage I and II ovarian cancer: a 7-year experienceS Chiara, S Mammoliti, C Oliva, et al.Maturitas|February 6, 2007
Efficacy on menopausal neurovegetative symptoms and some plasma lipids blood levels of an herbal product containing isoflavones and other plant extractsF Cancellieri, V De Leo, A D Genazzani, et al.Oncology|March 1, 1997
Paclitaxel plus ifosfamide in advanced ovarian cancer: a multicenter phase II studyL Miglietta, D Amoroso, M Bruzzone, et al.Oncology|September 1, 1996
Salvage chemotherapy with paclitaxel in platinum-resistant advanced ovarian cancer patientsM Bruzzone, E Catsafados, L Miglietta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-OvestP F Conte, M Bruzzone, F Carnino, et al.Gynecologic Oncology|June 1, 1997
Intraperitoneal carboplatin with or without interferon-alpha in advanced ovarian cancer patients with minimal residual disease at second look: a prospective randomized trial of 111 patients. G.O.N.O. Gruppo Oncologic Nord OvestM Bruzzone, A Rubagotti, A Gadducci, et al.Pageof 8